2015
DOI: 10.1186/s13039-015-0107-x
|View full text |Cite
|
Sign up to set email alerts
|

Double Xp11.22 deletion including SHROOM4 and CLCN5 associated with severe psychomotor retardation and Dent disease

Abstract: BackgroundHere we report the clinical and molecular characterization of two Xp11.22 deletions including SHROOM4 and CLCN5 genes. These deletions appeared in the same X chromosome of the same patient.ResultsThe patient is a six-year-old boy who presented hydrocephalus, severe psychomotor and growth retardation, facial dysmorphism and renal proximal tubulopathy associated with low-molecular-weight proteinuria, hypercalciuria, hyperaminoaciduria, hypophosphatemia and hyperuricemia. Standard and high resolution ka… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
20
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(21 citation statements)
references
References 20 publications
1
20
0
Order By: Relevance
“…In addition, a pathogenic missense mutation was identified in an unrelated large family, with carriers exhibiting mild-to-severe intellectual disability (ID) and increased susceptibility to seizures25. Recent studies reinforce the role of Shrm4 in ID678, however, how disruption of KIAA1202 causes these neuropathological conditions is unknown. Indeed, the role of Shrm4 in the brain is also unknown, but given the pathological profile, it may regulate GABA-mediated inhibition910.…”
mentioning
confidence: 99%
“…In addition, a pathogenic missense mutation was identified in an unrelated large family, with carriers exhibiting mild-to-severe intellectual disability (ID) and increased susceptibility to seizures25. Recent studies reinforce the role of Shrm4 in ID678, however, how disruption of KIAA1202 causes these neuropathological conditions is unknown. Indeed, the role of Shrm4 in the brain is also unknown, but given the pathological profile, it may regulate GABA-mediated inhibition910.…”
mentioning
confidence: 99%
“…SHROOM4, which takes part in the process of cytoskeletal organization, was reported critical for human brain structures and survival of some specific neuronal cell types [113]. The deletion of the SHROOM4 gene was believed may contribute to severe psychomotor retardation and Dent disease [114]. We observed the SHROOM4 gene was highly and specifically expressed in the pig cells of C0 (OLG) and C3 (OLG), while deprived in the mouse cells (Figure 4f).…”
Section: Divergence Of Brain Functions In Pig and Mousementioning
confidence: 66%
“…Shroom‐protein binding regulates the distribution and activity of rho kinase (rock), which influences cellular morphology and tissue morphogenesis via the actomyosin network . Shroom appears to play a role in cancer, neural‐tube defects, chronic kidney disease, and X‐linked intellectual disability . The shroom–rock interaction is thus interesting from a biological and medical perspective.…”
Section: Resultsmentioning
confidence: 99%